SCHEMBL20088117

SCHEMBL20088117

Cc1ccccc1-c1c(C(C)OCc2ccccc2)oc2cccc(C)c2c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ EDNRA P25101 1/20 0.36
▸ ATM Q13315 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MAOB P27338 4/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ PKM P14618 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13828423 0.89 BCL2 (0.39) HPGDKDM4EALDH1A1EDNRAMAOB
SCHEMBL13828448 0.89 BCL2 (0.39) HPGDKDM4EALDH1A1EDNRAMAOB
SCHEMBL13718641 0.89 BCL2 (0.39) HPGDKDM4EALDH1A1EDNRAMAOB
SCHEMBL21365159 0.76 AR (0.41) GAAEDNRAMAOBHTR2BBCL2
SCHEMBL13825908 0.74 BCL2 (0.35) ALDH1A1CYP1A2CYP2C9CYP2C19BCL2
SCHEMBL13826004 0.74 BCL2 (0.35) ALDH1A1CYP1A2CYP2C9CYP2C19BCL2
SCHEMBL16584880 0.73 CA1 (0.50) HPGDKDM4EALDH1A1TP53GAA
SCHEMBL15528063 0.73 CA1 (0.50) HPGDKDM4EALDH1A1TP53GAA
SCHEMBL13727404 0.71 KDM4E (0.41) HPGDKDM4EALDH1A1TP53GAA
SCHEMBL13826314 0.69 KDM4E (0.41) HPGDKDM4EALDH1A1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 — — US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 — — US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B HPGD 2242/4885KDM4E 2305/4885ALDH1A1 4204/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB HPGD 2692/4885KDM4E 2926/4885ALDH1A1 4530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback